Category Archives: News

DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology

New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic cancer, glioblastoma, and other lethal malignancies

NEW YORK, Aug. 26, 2026 /PRNewswire/ — DarwinHealth, a New York-based, AI-centric biotechnology company. today announced the introduction of Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology, a transformative scientific paradigm designed to address one of oncology’s greatest unsolved challenges: why the world’s deadliest cancers continue to evade even the most advanced targeted therapies.

The announcement accompanies the publication in Nature Genetics (https://www.nature.com/articles/s41588-026-02714-8) of a new perspective led by Dr. Andrea Califano and Dr. Kenneth P. Olive, driven by first author Dr. Pasquale Laise, PhD, alongside co-first authors Mikko Turunen, PhD, and Alvaro Curiel-Garcia, PhD.

The study, conducted at Columbia University, presents original research findings and argues that the next revolution in oncology will not come from discovering a single “miracle drug,” but from longitudinally decoding the multiple malignant cellular states that coexist within advanced, treatment-resistant tumors in individual patients.

The framework, undergirded by the company’s proprietary VIPER technology, licensed by Columbia exclusively to DarwinHealth, is supported by pioneering research led by DarwinHealth scientists Pasquale Laise, Mariano J. Alvarez, Andrea Califano, and their collaborators. Their single-cell systems biology studies, including the just published Nature Genetics report, demonstrate that pancreatic cancers comprise not one, but multiple, biologically distinct malignant cell states, each governed by unique regulatory programs and therapeutic vulnerabilities. 

From a landscape-changing perspective, this is the first study to convincingly show that vulnerabilities and desired drug responses among multiple cancer cell states that coexist in an individual patient’s tumor (in this case, pancreatic cancer) are virtually identically conserved in patients with the same kind of cancer. In other words, at the time of disease onset, all patients with a particular kind of cancer—pancreatic cancer, glioblastoma, breast cancer, melanoma, prostate cancer, and many others—harbor a recurring, predictable, and co-existing mix of multiple cancer cell state abnormalities, all of which must be targeted relatively simultaneously to achieve optimal treatment results.

By extension, enduring treatment responses—and most importantly, definitive cures—especially for our most lethal and resistant tumors, will likely come, not from any single bullet, but from decoding the cancer cell states and then deploying multi-drug combinations directed at each abnormal state early in the treatment course. As the study shows, both decoding and targeting strategies can be systematically identified using AI-based algorithms, such as those developed and commercialized by DarwinHealth.

Together, the advances reported in Nature Genetics establish the scientific foundations and drug development roadmaps for a new generation of precision oncology treatments based not simply on identifying genetic mutations, but on decoding the regulatory architecture that determines how every malignant cell behaves—and how it can be therapeutically eliminated. Based on these recent results, as well as previous and yet-to-come studies, these technologies developed and refined by DarwinHealth are paving the way to more universal and more effective combination therapies for cancers shown to be resistant to current treatments and, therefore, responsible for invariably high mortality rates, frequently in excess of 90%.

Beyond Precision Oncology

For decades, precision oncology has largely defined tumors by their genomic mutations, with therapies designed to inhibit individual oncogenic drivers. While this strategy has produced important clinical advances, durable responses in highly resistant cancers such as pancreatic cancer and glioblastoma remain uncommon because tumors continually evolve new, resistant cellular populations.

Quantum Cancer Biology proposes a fundamentally different view.

Rather than treating cancer as a single disease, the framework recognizes each tumor as a dynamic ecosystem composed of multiple interacting malignant cell states. Each cellular state is controlled by its own regulatory circuitry, possesses its own survival mechanisms, and exhibits its own therapeutic sensitivities.

The central challenge, therefore, is not simply identifying a mutation—it is identifying —and in this case, using AI to decode—every clinically relevant cancer cell state within an individual patient’s tumor and determining the optimal therapeutic strategy for each.

DarwinHealth co-founder Califano has also recently published a review in the journal Cell, “Fifteen challenges for generative AI applications to cell biology” (https://www.cell.com/cell/fulltext/S0092-8674(26)00802-0), further illuminating the role of AI for network-based predictions to guide cancer treatment.

Making the Invisible Visible

DarwinHealth’s drug discovery platform leverages single-cell transcriptomics, AI, and regulatory network inference to infer master regulatory protein activity. The company’s technology rigorously validates the functional reality and causality of these cellular states through multi-modal integration with ATAC-seq, lineage tracing, and CRISPR perturbations.

Unlike conventional gene-expression profiling—which merely catalogs transcript abundance—DarwinHealth’s systems biology framework pinpoints the causal drivers maintaining malignant states and identifies the molecular checkpoints most likely to collapse them.

This approach transforms complex tumor landscapes into high-resolution functional maps, revealing previously invisible targets for precision oncology.

Pancreatic Cancer as the Prototype

The power of this approach is illustrated by the original work just published in Nature Genetics.

Using regulatory network analysis of single-cell transcriptomic data, the investigators identified six highly conserved malignant pancreatic cancer cell states organized into three developmental lineages. Importantly, these regulatory states proved remarkably reproducible across independent patient cohorts, pancreatic cancer cell lines, and patient-derived xenograft models, providing a robust mechanistic taxonomy of pancreatic cancer heterogeneity. 

Rather than merely describing tumor diversity, the investigators identified the Master Regulator proteins responsible for maintaining each malignant state and experimentally demonstrated that these regulatory programs represent therapeutically actionable cellular dependencies. 

These findings provide a mechanistic roadmap for developing rational combination therapies capable of simultaneously targeting multiple malignant populations within a single tumor.

Toward Rational Combination Therapy for Cancer

Drug resistance remains the leading cause of mortality in patients with advanced cancer.When one therapeutic agent successfully eliminates drug-sensitive cells, resistant populations frequently survive, expand, and ultimately repopulate the tumor.

Quantum Cancer Biology reframes this problem.

Instead of asking which single drug best treats a tumor, the framework asks:

Which combination of therapeutics is required to eliminate every biologically distinct malignant cell state that exists within that patient’s cancer?

By computationally identifying these states and their regulatory dependencies, DarwinHealth seeks to enable the rational design of multi-agent therapeutic strategies that address the complete cellular architecture of resistant cancers, rather than only their dominant populations. This concept aligns with the company’s broader perspective on treating tumors as complex “oncosystems.” 

Leadership Perspectives

“The future of precision oncology lies in understanding the regulatory logic that determines cellular identity—not merely cataloging mutations or measuring gene expression. By reconstructing the regulatory networks that control individual cancer cell states, we can identify the molecular mechanisms that sustain them and, ultimately, the therapeutic strategies capable of disrupting them.”

— Andrea Califano, Dr.

Co-Founder, DarwinHealth; President, New York Biohub; Clyde and Helen Wu Professor of Chemical Systems Biology, Columbia University

“Single-cell transcriptomics provides unprecedented resolution of tumor heterogeneity, but understanding how those cellular states are established and maintained requires systems-level analysis. By identifying the Master Regulator proteins controlling each malignant state, we can move from describing tumor diversity to defining actionable therapeutic vulnerabilities.”

— Pasquale Laise, PhD

Senior Director, Single-Cell Systems Pharmacology, DarwinHealth

“For decades, oncology has searched for better drugs to treat individual cancers. Quantum Cancer Biology begins with a different premise: that many advanced tumors are not one cancer, but many biologically distinct cancers coexisting within the same patient. Our mission is to decode those hidden cellular states and transform that knowledge into rational—almost invariably, combination—therapeutic strategies that target the full complement of regulatory network derangements.”

— Gideon Bosker, MD

Chief Executive Officer and Co-Founder, DarwinHealth

A New Framework for Precision Oncology

DarwinHealth believes that Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology represents a foundational advance in cancer systems biology.

By integrating single-cell transcriptomics, regulatory network inference, inferential artificial intelligence, and systems pharmacology, the framework seeks to identify the smallest rational combination of therapeutic interventions capable of targeting the full spectrum of malignant cellular states within each patient’s tumor.

Initially developed and validated in pancreatic and brain cancer, the framework is now being extended across additional highly resistant malignancies—including glioblastoma and other aggressive solid tumors—with the goal of accelerating the development of more effective precision combination therapies.

As oncology enters an era defined by cellular resolution rather than population averages, DarwinHealth believes Quantum Cancer Biology provides the conceptual and computational foundation for decoding cancer’s hidden complexity—and translating that knowledge into more durable therapeutic outcomes.

About DarwinHealth

Founded by Gideon Bosker and Andrea Califano in 2016, DarwinHealth is a New York City-based precision oncology company pioneering systems biology and artificial intelligence technologies that decode regulatory mechanisms governing cancer. By integrating regulatory network biology, single-cell analysis, and computational pharmacology, DarwinHealth develops predictive technologies to identify patient-specific therapeutic vulnerabilities and accelerate the development of next-generation precision cancer therapies.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/darwinhealth-introduces-quantum-cancer-biology-a-cell-state-systems-biology-framework-for-precision-oncology-302860552.html

Cellebrite Brings Battlefield Intelligence to the Armed Forces with Launch of Portable Tactical Extraction Kit (C-TEK)

Built around Cellebrite’s industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their missions

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 26, 2026 /PRNewswire/ — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the launch of the Cellebrite Tactical Extraction Kit (C-TEK), a ruggedized, all-in-one mobile forensics field kit packaged in a standard-size backpack, giving military teams the hardware, software and power to access and analyze devices at the point of capture. Designed for units operating in disconnected environments, C-TEK equips the armed forces to act on device data in real time, strengthening tactical, operational and strategic decision-making at the speed modern conflict demands.

As digital devices increasingly shape the course of modern conflict, the intelligence they hold is now critical to a mission, revealing locations, connections and operational plans. However, this intelligence has a short half-life. When a military unit has only minutes to complete a mission, the value of digital data can be lost if the device isn’t extracted on the spot. Mission-critical data and intelligence are lost or an enemy battlefield advantage gained. Furthermore, sending devices to a lab and waiting days or months for analysis often means the information may be outdated and unusable by the time it is returned.

C-TEK closes that gap by bringing extraction and analysis capabilities to the edge. It is a ready-made bundle of ruggedized hardware and Cellebrite software engineered to access a wide range of phones, computers and other devices in the field. C-TEK is designed first for military units operating in disconnected environments, where sensitive site exploitation is a core mission task and the speed of the data extraction directly affects follow-on operations. Rather than routing devices to a lab or relying on a single trained analyst, units can deploy C-TEK across the team, extending the capability to every operator.

“Battlefield intelligence has an expiration date measured in minutes, not months,” said Marcus Jewell, chief revenue officer at Cellebrite. “With C-TEK, we are equipping the armed forces — not just a trained intelligence analyst — to capture and act on that data before it disappears. This is about giving units the tools to fulfill their missions with the intelligence they need, exactly when and where it matters most. We are committed to putting more cutting-edge intelligence tools directly in the hands of the operators who protect nations, so that no critical piece of intelligence is left behind.”

C-TEK marks the first step in a broader Cellebrite effort to build an end-to-end field intelligence solution for defense and intelligence customers around the world. The Company is developing a portable version of its Pathfinder analytics platform, an on-premises AI capability, an upgraded CFID V4 for drone forensics and a mobile kit that enables small teams to quickly set up digital forensics operations without existing local infrastructure for short-term deployments. These innovations will expand and extend Cellebrite’s capabilities further toward the edge of operations.

About Cellebrite

Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency, and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit www.cellebrite.com and https://investors.cellebrite.com, and find us on social media @Cellebrite.

Media 

Jackie Labrecque 

Director, PR and Executive Communications 

jackie.labrecque@cellebrite.com   

+1 771.241.7010 

Investor Relations 

Andrew Kramer 

Vice President, Investor Relations & Treasury 

investors@cellebrite.com  

+1 973.206.7760

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cellebrite-brings-battlefield-intelligence-to-the-armed-forces-with-launch-of-portable-tactical-extraction-kit-c-tek-302859870.html

Gradiant Expands Global Engineering Center in Coimbatore to Strengthen International Project Execution

Expansion more than doubles engineering workforce,

strengthening India’s role in Gradiant’s global operations

COIMBATORE, India, Aug. 26, 2026 /PRNewswire/ — Gradiant, the Water Layer of the AI Economy, today announced the expansion of its Global Engineering Center (GEC) in Coimbatore, growing its engineering and project execution capabilities in India as it scales its global business across semiconductors, advanced manufacturing and other mission-critical industries.

The expansion will increase the GEC’s engineering workforce from approximately 100 to more than 200 professionals. The expanded center will bring together multidisciplinary capabilities spanning process, detailed design, and project engineering, enabling the team to take greater ownership of engineering and design for Gradiant’s global projects.

“Coimbatore combines strong engineering talent with a deep industrial heritage, making it an important location for Gradiant as we scale our global engineering capabilities. This expansion strengthens our multidisciplinary organization and enables greater ownership of complex projects for customers across markets,” said Govind Alagappan, COO, Gradiant.

The investment will create opportunities across engineering disciplines, with professionals gaining exposure to international projects, advanced water and wastewater technologies, global engineering standards and multidisciplinary project execution. Experienced engineers will also help develop the next generation of talent, creating pathways into technical leadership, project management and global project-facing roles.

Coimbatore’s strong engineering talent pool and established industrial and manufacturing ecosystem make it a strategic location for Gradiant’s continued investment. The center will support Gradiant’s growing global project portfolio as demand for advanced water and wastewater solutions rises across semiconductors, advanced manufacturing, renewable energy and pharmaceuticals.

As global investment in AI infrastructure, semiconductor manufacturing and data centers accelerates, reliable water treatment and wastewater recycling are becoming increasingly critical to supporting these water-intensive industries.

“India is becoming increasingly important to Gradiant’s global growth strategy. Our investment in Coimbatore allows us to combine India’s engineering talent with our global project pipeline, strengthening our ability to support customers in India and around the world,” said Hari Prasad, Managing Director of India, Gradiant.

Gradiant has a growing track record in India, delivering advanced water reuse and wastewater treatment solutions for industries including renewable energy and advanced manufacturing. Its India portfolio includes a 10,000 m³/day wastewater recycling project for a solar PV manufacturing facility in Tamil Nadu, demonstrating its ability to support large-scale, water-intensive industrial operations. The company has also delivered a fully integrated ultrapure water (UPW), wastewater treatment & recycling, and zero liquid discharge (ZLD) facility for a leading U.S. semiconductor manufacturer at its Gujarat site, further demonstrating its capabilities in India’s rapidly expanding semiconductor and advanced manufacturing ecosystem.

Over the next three years, Gradiant plans to further build out its engineering capabilities in India, with its Chennai and Coimbatore operations forming a strategic global engineering hub supporting international projects.

The Coimbatore expansion reinforces Gradiant’s long-term commitment to India as both a growing market and a strategic engineering base for its global operations, while creating opportunities for Indian engineering professionals to contribute to complex projects and advanced water infrastructure worldwide.

About Gradiant

Gradiant is the Water Layer of the AI Economy. Founded at MIT and headquartered in Boston, Gradiant builds the water and wastewater infrastructure behind AI’s build-out, from chips and data centers to the energy and industries that depend on them. As AI demand accelerates, water is becoming the resource that determines what can be built. Gradiant’s technologies reduce what industry withdraws, reclaim what it would waste, and renew clean water to nature, with more than 3,000 treatment plants built across 92 countries. Learn more at gradiant.com.

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/gradiant-expands-global-engineering-center-in-coimbatore-to-strengthen-international-project-execution-302860515.html

Walovi Accelerates Global Push with WALOVI Singapore HQ Launch and Trio of Southeast Asia Deals

SINGAPORE, Aug. 26, 2026 /PRNewswire/ — WALOVI officially launched its WALOVI Singapore International Headquarters, unveiled its new “X-Hero natural energy electrolyte drink” for the first time outside China, and signed three strategic partnerships, marking a major milestone in global expansion.

The Singapore HQ will serve as WALOVI’s global operations hub, overseeing brand promotion, channel management, cross-border investment, and talent acquisition. It will also explore local filling and co-manufacturing models to sharpen regional responsiveness. The choice of Singapore leverages its status as Asia-Pacific’s capital gateway and home to one-third of Fortune 500 regional HQs, while Southeast Asia has become Walovi’s fastest-growing overseas market—with Vietnam, Cambodia, and Malaysia all posting 100% year-on-year export growth in H1 2026.

“WALOVI’s globalization strategy is to carve out a clear niche in the global beverage market—to become the world’s leading natural plant-based beverage brand. WALOVI’s arrival in Singapore and the establishment of its international headquarters is not about ‘going out’—it’s about ‘growing up,’ connecting consumers worldwide through a natural, healthy lifestyle and natural plant‑based beverages,” said Fang Dafeng, Chairman of WALOVI Great Health.

The newly launched X-Hero natural energy electrolyte drink—formulated with ginseng and coffee bean extracts, free from synthetic taurine and artificial caffeine—taps into the shift from “post-exhaustion fixes” to “sustained daily vitality.” With Southeast Asia’s tropical climate and a US$21.8 billion functional drink market (Euromonitor 2025), the product is positioned for strong regional uptake.

Three agreements were inked: with Nanyang Technological University for brand and consumer research, with Baosteel Packaging for supply chain co-manufacturing in Vietnam, Malaysia and Cambodia, and with Sheng Sheng Food for Singapore retail distribution – operationalizing Walovi’s PCBCI global model of Product, Channel, Brand, Culture, and Investment.

Backed by global endorsers including footballer Erling Haaland and actor Zhang Linghe, Walovi has sustained over 25% CAGR in international sales. As consumer preference shifts toward natural, functional, clean-label beverages—now embraced by 96% of buyers (Ipsos 2025)—WALOVI is well-positioned for further growth.

With Singapore as its strategic pivot and the world as its horizon, every step WALOVI takes in Southeast Asia follows a steadfast localization strategy. Riding the global wave of health-conscious consumption, WALOVI has already taken its place on the international stage and is steadily advancing toward becoming the world’s leading natural plant-based beverage enterprise.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/walovi-accelerates-global-push-with-walovi-singapore-hq-launch-and-trio-of-southeast-asia-deals-302860359.html

Bhavan’s College MSEED and Reliance Animation Academy Enter into a Strategic Agreement to Launch Graphics & Animation Programs

MUMBAI, India, Aug. 26, 2026 /PRNewswire/ — Bhavan’s College MSEED (Management School of Events & Experience Design) has entered into an official agreement with Reliance Animation Studios Private Limited, through its education brand Reliance Animation Academy (RAA), to introduce a new suite of academic programs in Animation, VFX, Gaming & Filmmaking at the Bhavan’s MSEED campus in Mumbai.

The agreement brings together MSEED’s academic ecosystem and institutional association with Bhavan’s College and the University of Mumbai with Reliance Animation Academy’s expertise in animation, visual effects, filmmaking and related creative disciplines. The association aims to provide students with industry-oriented education and practical exposure in the rapidly evolving media and entertainment landscape.

The agreement was formalised in the presence of Jimmy Choudhary, Director, MSEED Private Limited; Joshua Newman, VP – Marketing & Partnerships, MSEED; Tejonidhi Bhandare, CEO, Reliance Animation Studios Private Limited; and Sandeep Shetty, Business Head, Reliance Animation Academy. Their presence marked the formal commencement of the academic association between the two organisations.

Academic Programs:

Under the agreement, the programs will be offered under the nomenclature ‘Bhavan’s MSEED – Animation, VFX & Filmmaking – Powered by Reliance Animation Academy’.

The academic portfolio will include:

B.Sc. in Graphics & Animation (Proposed) – 3-year undergraduate program

Diploma in Graphics, Animation & VFX – 24-month program

Certificate Program in Graphics, Animation & VFX – 12-month program

Certificate Program in Graphics & Editing – 6-month program

The program will combine structured academic learning with practical training across animation, graphics, visual effects, filmmaking and other emerging creative disciplines.

Reliance Animation Academy will contribute its curriculum, academic content, qualified faculty and training expertise, while MSEED will oversee institutional coordination, academic approvals, admissions, academic frameworks and program delivery in association with Bhavan’s College.

Industry-Ready Learning Infrastructure:

A key feature of the initiative will be the creation of specialised learning infrastructure at the MSEED campus.

The learning environment will further be supported by industry-standard creative software and equipment for animation, VFX, graphic design and filmmaking education.

Industry Exposure and Student Outreach:

The association will place strong emphasis on student outreach, practical learning and industry orientation. From October 2026 onwards, MSEED and Reliance Animation Academy will undertake joint outreach initiatives, including workshops and visits to coaching classes and educational institutions, to introduce prospective students to career opportunities across the media and entertainment sector.

On the occasion, Jimmy Choudhary, Director, MSEED Private Limited, said, “The future of education lies at the intersection of academic learning, technology and industry practice. Our association with Reliance Animation Academy allows us to bring a specialised Graphics & Animation education ecosystem to Bhavan’s MSEED. We want students to learn not only the fundamentals of the creative industries but also develop the technical skills, practical exposure and creative confidence required to build meaningful careers in a rapidly evolving media landscape.”

Adding to the same, Tejonidhi Bhandare, CEO, Reliance Animation Studios Private Limited, said, “Animation, visual effects, graphics and filmmaking are transforming the way stories and experiences are created and consumed. Through this association with Bhavan’s College MSEED, we aim to provide students with access to relevant academic content, specialised infrastructure and industry-oriented training that prepares them for the opportunities emerging across the global media and entertainment ecosystem.”

The agreement establishes a long-term academic association between the two organisations, with the programs designed to create a stronger bridge between higher education and the professional requirements of the media and entertainment industry.

About Bhavan’s College MSEED

Bhavan’s College MSEED (Management School of Events & Experience Design) is an academic institution associated with Bhavan’s College, Mumbai, and focuses on industry-oriented education in emerging creative and experiential disciplines. MSEED is affiliated with the University of Mumbai through its association with Bhavan’s College and continues to expand its academic offerings in response to evolving industry requirements.

About Reliance Animation Academy

Reliance Animation Academy, a division of Reliance Animation Studios and a part of Reliance Entertainment has travelled an amazing path since its inception in 2009, prospering on its goal of building a training center network all across India and fulfilling its promise of giving industry-specific education to today’s youth.

Reliance Animation Academy is a leading institute in India offering career-focused programs in Animation, VFX, Gaming, Graphics, and Film Making. With a strong network of training centers, the academy is committed to developing industry-ready creative professionals through hands-on learning and expert mentorship.

Reliance Animation Studios is an award-winning studio in partnership with noted filmmaker ROHIT SHETTY, best known for delivering IP-driven animation content like Little Singham, Golmaal Jr., Little Krishna, and Smashing Simmba.

Media contact: Tasneem Limbdiwala, tasneem@mseededucation.com, +91 9967547967

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/bhavans-college-mseed-and-reliance-animation-academy-enter-into-a-strategic-agreement-to-launch-graphics–animation-programs-302860377.html

Legal AI Challenger Ask.Legal Expands to Australia and Singapore with AI Legal Analysis and Document Generation

Ask.Legal expands jurisdiction-specific legal AI across four common-law markets with AI legal analysis and document generation

LONDON and HONG KONG and SINGAPORE and SYDNEY, Aug. 26, 2026 /PRNewswire/ — Ask.Legal, the legal AI platform developed with limited funding, has expanded to Australia and Singapore after gaining traction in Hong Kong and England and Wales, extending its jurisdiction-specific legal analysis across four major common-law markets:

Hong Kong | England & Wales | Singapore | Australia

Ask.Legal is gaining wider adoption across Asia-Pacific common-law markets, driven largely by organic discovery, referrals and word of mouth. Users can describe a legal issue in ordinary language and receive structured analysis based on the legislation and case law of the selected jurisdiction.

While many leading legal AI companies have raised hundreds of millions of dollars to build enterprise platforms for the world’s largest law firms and corporate legal departments, Ask.Legal is taking a different approach: making advanced legal AI accessible to smaller law firms, businesses, professionals and everyday users without requiring an expensive enterprise subscription.

Its document generation capability builds on the expertise developed through DocLegal.ai, Ask.Legal‘s sister AI legal document platform. Users can move from analysing a legal issue to preparing a tailored first draft of a letter, agreement, notice, legal submission or other legal document within the same workflow.

“Legal AI should be available to everyone—not just Big Law,” said Kim Chan, Founder of Ask.Legal. “Whether you are an individual, a business, a lawyer or an AI agent, you should be able to access jurisdiction-specific legal analysis when you need it and pay only for the tokens you use, rather than thousands of dollars per seat in subscription fees.”

Ask.Legal can assist with legal issue identification, preliminary legal analysis, document review, document generation and preliminary drafting. The platform reports a tested hallucination rate of under 3%, and user data is not used to train its AI models.

Ask.Legal operates on a pay-as-you-go token model, with no compulsory monthly or annual subscription. New users can currently receive 100,000 introductory tokens upon registration for free trial.

The Australia and Singapore launches mark the next stage in Ask.Legal‘s development from a Hong Kong and England & Wales legal AI platform into a broader common-law legal technology ecosystem. Ask.Legal covers all 6 Australian states and 2 territories, as well as Australian federal law.

About Ask.Legal

Ask.Legal is an AI-powered legal analysis, document generation and legal automation platform developed by DocPro Limited. It provides jurisdiction-specific legal capabilities for Hong Kong, England & Wales, Singapore and Australia.

The platform combines conversational legal analysis with document generation, providing one of the best and most affordable access to legal AI in the market.

Ask.Legal provides general legal information and AI-generated analysis and documents. It is not a law firm and its output does not constitute legal advice.

View original content:https://www.prnewswire.co.uk/news-releases/legal-ai-challenger-asklegal-expands-to-australia-and-singapore-with-ai-legal-analysis-and-document-generation-302860064.html

IntelliDB Enterprise Partners With Yotta To Deliver Sovereign & AI Database Infrastructure In India

GURUGRAM, India, Aug. 26, 2026 /PRNewswire/ — IntelliDB Enterprise, India’s first AI-Powered database management platform, today announced a strategic partnership with Yotta Data Services, a leading Indian provider of sovereign cloud, AI infrastructure and hyperscale data centre services to deliver sovereign, AI-ready database infrastructure hosted on Yotta’s sovereign cloud and AI infrastructure in India.

The partnership is aimed at enterprises, government organizations, and regulated industries looking to modernize database infrastructure and build AI applications while ensuring complete data sovereignty and regulatory compliance. Together, the companies will offer fully managed database services hosted on Yotta’s sovereign cloud infrastructure, enabling enterprises to modernize mission-critical workloads while maintaining complete data sovereignty and regulatory compliance.

IntelliDB’s platform is built on PostgreSQL’s engine which is one of the world’s most widely used database technologies with IntelliDB’s own core features and AI capabilities. 

What IntelliDB Brings to the Table

IntelliDB Enterprise is built to make databases secure, scalable and smarter to run. Its AI-Powered features help businesses detect problems before they cause downtime, tune performance, and reduce the manual work a database team usually must do, all while keeping a human in the loop. Every AI action IntelliDB takes is logged and can be reviewed; nothing happens without oversight. IntelliDB also powers a new generation of AI-based applications, things like faster and more accurate search, and tools that can find and explain information from a company’s own database.

IntelliDB already meets some of the toughest data protection and security standards used by hospitals, banks, and global businesses, including HIPAA, GDPR, SOC-1, SOC-2, and PCI-DSS, giving customers a headstart on compliance rather than a project to build it from scratch.

Why This Matters

More companies want to use Artificial Intelligence in their everyday software, but AI tools need a database that can keep up, one that’s fast, secure, and able to understand the meaning behind information, not just store it.

By combining IntelliDB’s database platform with Yotta’s sovereign cloud and AI infrastructure, businesses can now build these AI-powered applications without sending sensitive data outside the country and meeting India’s data protection requirements by design, not as an afterthought.

Together, IntelliDB and Yotta provide organizations with an integrated platform that combines intelligent database management with secure, scalable and sovereign infrastructure for enterprise AI and data-intensive applications.

This partnership allows customers to:

• Run AI-powered applications on a database built for them, hosted on Yotta’s sovereign cloud infrastructure.
• Get a fully managed database service, so internal IT teams spend less time on day-to-day maintenance.
• Meet strict data protection and compliance standards without building that capability from scratch.
• Modernize older data infrastructure using IntelliDB’s specialised migration toolkit on Yotta’s secure, sovereign cloud infrastructure.
• Grow from everyday business applications to advanced AI applications on the same platform.

Gagandeep Singh, Co-Founder & CEO, IntelliDB Enterprise, said: “AI initiatives and scaling for any organisation is only as strong as the data infrastructure underneath it. This partnership brings our secure, AI-powered and intelligent database platform to more Indian enterprises and government organizations, hosted entirely within India. Together with Yotta, we are simplifying database operations while giving customers a secure, scalable, AI-powered platform. That combination of intelligence and control is what enterprises, and government organizations need to build modern data infrastructure.”

Sunil Gupta, Co-founder, Managing Director & CEO, Yotta Data Services, said: “The next wave of enterprise transformation will be driven by AI, and every AI application depends on trusted, intelligent and sovereign data. At Yotta, we are building India’s most comprehensive Sovereign AI ecosystem – from hyperscale data centres, sovereign cloud and AI infrastructure to AI platforms and enterprise services. Our partnership with IntelliDB Enterprise strengthens this vision by adding an AI-ready database layer that enables organizations to build secure, scalable, and future-ready AI applications entirely on India’s sovereign digital infrastructure. Together, we are empowering enterprises and government organizations to innovate faster while maintaining complete control over their data.”

About IntelliDB Enterprise

IntelliDB Enterprise is a next-generation AI-powered enterprise database platform built on PostgreSQL, delivering enterprise-grade performance, security, and scalability for mission-critical applications. The platform combines intelligent automation with advanced database capabilities to help organizations reduce operational complexity, improve performance, and accelerate digital transformation across on-premises, cloud, and hybrid environments. 

For more information, visit www.intellidbenterprise.com

About Yotta Data Services

Yotta Data Services is a sovereign cloud infrastructure and platform services provider, offering cloud, AI cloud, data centre hosting, connectivity, media tech and cybersecurity services; managed applications; and a wide range of managed IT services. Yotta operates its cloud regions at its hyperscale data centre parks in Panvel (Navi Mumbai) and Greater Noida (Delhi NCR). Yotta’s homegrown, open-source-based Sovereign hyperscale cloud, Yntraa, is MeitY empanelled (VCC and GCC). Yotta has also launched Shakti Cloud, a platform providing enterprises with a comprehensive suite of AI services including AI labs, AI workspaces, Shakti Studio AI Inference platform, access to NVIDIA NIM services, and Kubernetes clusters with GPU resources. Yotta is the only NVIDIA Cloud Partner (NCP) across the APAC region to be part of the NVIDIA Exemplar cloud initiative and is one of only six Reference Architecture Platform NCPs globally.

For more information, visit www.yotta.com

Photo: https://mma.prnewswire.com/media/3008872/IDB_x_Yotta_Partnership.jpg

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/intellidb-enterprise-partners-with-yotta-to-deliver-sovereign–ai-database-infrastructure-in-india-302860223.html

CARD91 Introduces Five-Point Credit Lifecycle Consistency Framework for Credit Line on UPI

The issuer-readiness framework focuses on keeping credit records aligned across different facilities, payments, refunds, reversals, repayments and EMI conversions

BENGALURU, India, Aug. 26, 2026 /PRNewswire/ — CARD91, a payments infrastructure company, today introduced its Credit Lifecycle Consistency Framework, a five-point industry framework designed to help banks assess their operational readiness for Credit Line on UPI (CLOU).

The framework focuses on ensuring that credit limits, outstanding balances and customer records remain accurate as payments move through refunds, reversals, repayments, EMI conversions and other lifecycle events.

The announcement comes as UPI enters its second decade. According to the Press Information Bureau, the network now connects 741 live banks and processed 2,365.8 crore transactions worth ₹29.87 lakh crore in July 2026. These figures represent the overall UPI network and demonstrate the operating scale within which UPI-based credit is developing.

The RBI’s Fourth Amendment Directions on Credit Facilities, issued on June 23, 2026, clarified that the prudential treatment of UPI-linked credit must be determined by the nature of the underlying credit facility—not by the payment channel, instrument or technology used. The facility’s terms must also form part of the bank’s credit policy and comply with applicable regulations.

A successful UPI payment is only one event in a continuing credit relationship. Subsequent refunds, reversals, repayments or EMI conversions can alter the customer’s available credit, outstanding dues and repayment schedule.

“Speed gets the customer through checkout, but consistency determines whether they trust the credit product,” said Ajay Pandey, CEO, CARD91. “Each payment and subsequent credit event must receive the correct treatment for the underlying facility so that the bank and the customer continue to see the same financial position.”

The Credit Lifecycle Consistency Framework

1. Apply facility-specific credit treatment

Interest-free, interest-bearing, fixed-term and revolving facilities may require different treatment of limits, repayments, refunds and outstanding balances.

2. Connect payment and credit records

UPI transactions and subsequent credit events should remain connected with the appropriate customer account. Refunds, reversals and repayments must update the relevant records accurately.

3. Align controls with bank policy

Transaction value, velocity and merchant-category controls—as well as portfolio actions such as limit changes and suspensions—should reflect the bank’s credit policy and customer consent.

4. Reconcile repayments and EMI conversions

Repayments should be applied to the correct account, while EMI conversions should update the instalment schedule without duplicating the outstanding amount.

5. Maintain customer visibility and traceability

Available credit, outstanding dues and repayment obligations should remain consistent across applications, statements and alerts. Disputes, delayed reversals and manual corrections should follow a documented and reviewable process.

Lifecycle consistency means updating the appropriate credit records as each event is processed. The framework does not prescribe a universal processing timeframe or replace RBI requirements and individual bank credit policies.

For example, if a customer uses ₹10,000 from a ₹50,000 revolving credit line, the available credit would ordinarily fall to ₹40,000. Any subsequent refund, reversal, repayment or EMI conversion must update the relevant records according to the facility’s terms. A fixed-term loan may require different treatment, reinforcing why payment processing cannot be separated from the underlying credit product.

Where CLOU is delivered through a digital-lending journey, the RBI Digital Lending Directions, 2025 may also apply to credit assessment, disclosures, servicing, repayment, grievance redressal and credit-information reporting.

CARD91’s perspective is informed by its work on Nimbus, its Credit Line Management System. Nimbus supports different credit structures and connects credit lifecycle management with CARD91’s NPCI-certified UPI 2.0 switch. Its publicly described capabilities include transaction and portfolio controls, consent management, EMI conversion, reconciliation and dispute resolution.

Technology should not determine lending policy or replace regulatory judgement. Its role is to help keep bank policy, transaction records and customer credit positions aligned.

As credit becomes an additional funding source on UPI, its next trust test will begin after the payment: whether every subsequent credit event leaves the bank and the customer with the same financial truth.

About CARD91

CARD91 is a payments and onboarding risk infrastructure provider, enabling regulated entities to launch and scale customer programs with ease. The platform supports seamless onboarding journeys, fraud detection, credit decisioning, card issuance across credit, prepaid, and forex, and UPI stack capabilities across issuance and acquiring.

Through its NPCI-certified capabilities and technology stack, CARD91 helps institutions design bespoke customer payment programs and market them with speed, security, and a seamless digital experience. Built by a team of bankers and technologists and proudly made in India, CARD91 operates across key financial hubs, including Mumbai, Bangalore, Delhi, and Chennai.

For more information, visit https://card91.io/ or contact sales@card91.io.

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/card91-introduces-five-point-credit-lifecycle-consistency-framework-for-credit-line-on-upi-302859438.html

RBI’s Proposed Shift from Revolving Credit to Term Loans: SwiffyLabs Lending Platform Already Supports the New Construct

BENGALURU, India, Aug. 26, 2026 /PRNewswire/ — The Reserve Bank of India’s latest draft regulations proposing restrictions on revolving credit facilities for most NBFCs could mark a significant shift in the way lenders design and manage credit-line products.

Under the proposed framework, NBFCs would generally be required to offer credit products in the nature of term loans, rather than revolving facilities where repayment of principal automatically restores the available borrowing limit. The proposed change could have implications for several lending products that currently rely on drawdown, repayment and redraw mechanisms.

While the regulatory change will require lenders to reassess their product structures, it also presents a technology challenge. NBFCs will need lending platforms capable of supporting multiple drawdowns, individual repayment schedules, amortisation and servicing workflows, while ensuring that repaid principal does not automatically replenish the sanctioned limit.

SwiffyLabs Lending Platform is already equipped to support this construct.

The platform supports a non-revolving credit-line structure that allows NBFCs to retain the operational flexibility of multiple drawdowns within an approved sanction, while ensuring that principal once repaid does not replenish the available sanctioned amount. This provides lenders with a technology-led pathway to adapt existing products to the proposed regulatory framework without fundamentally redesigning their customer journeys.

The capability can be particularly relevant for products such as Loan Against Securities (LAS) and other credit-line offerings that traditionally rely on flexible drawdown and repayment mechanisms. By supporting multiple drawdowns while maintaining a non-replenishing sanctioned limit, SwiffyLabs enables lenders to transition these products towards a term-loan construct with minimal product and technology disruption.

“Regulatory changes of this nature require lenders to rethink not just their product structures, but also the underlying technology that manages those products,” said Vivek Sinha, VP Products, SwiffyLabs. “Our objective has always been to build a lending platform that can give financial institutions the flexibility to launch and adapt credit products while maintaining strong regulatory alignment. The non-revolving credit construct is an example of how technology can help NBFCs respond to evolving regulatory requirements without compromising customer experience.”

The proposed RBI framework is likely to prompt NBFCs to evaluate their existing credit products, technology architecture and operational processes. For lenders with significant exposure to revolving or flexible credit products, the ability to transition to compliant structures without extensive technology redevelopment could become an important consideration.

About SwiffyLabs

SwiffyLabs is a next-generation technology platform for the BFSI sector, enabling financial institutions to build, launch and scale digital financial products through its integrated suite of Lending, Payments and SwiffyLabs Studios. Its Lending platform provides a modular technology stack spanning loan origination, loan management, collateral management, risk workflows, servicing and digital product journeys across multiple credit products, while its Payments platform enables institutions to build and manage digital payment products and transaction workflows. SwiffyLabs Studios provides configurable, plug-and-play technology components that help financial institutions solve specific operational and technology challenges, including reconciliation, automation and other high-efficiency workflows, without requiring large-scale technology redevelopment. Built on a modular and API-first architecture, SwiffyLabs enables institutions to configure products faster, integrate with existing technology ecosystems and adapt to evolving regulatory and business requirements with greater speed, flexibility and cost efficiency.

For more information, visit the website www.swiffylabs.com.

Media Contact

Ajita Chakladar

Email: sales@swiffylabs.com 

Logo: https://mma.prnewswire.com/media/3008875/SwiffyLabs_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/rbis-proposed-shift-from-revolving-credit-to-term-loans-swiffylabs-lending-platform-already-supports-the-new-construct-302860186.html

Antaisolar Joins United Nations Global Compact and Releases 2025 ESG Report

XIAMEN, China, Aug. 26, 2026 /PRNewswire/ — Antaisolar, a leading expert in digital and intelligent PV mounting system solutions, announced its official participation in the United Nations Global Compact (UNGC) and the release of its 2025 ESG Report, marking two key milestones in the company’s ongoing sustainability efforts.

As a UNGC participant, Antaisolar will incorporate the UNGC Ten Principles into its RAISE sustainability strategy, which is structured around five pillars: Sound Governance, Premium Products, Equity & Inclusion, Ecological Co-existence and Shared Prosperity. Aligned with the UN Sustainable Development Goals (SDGs), the strategy focuses on supply-chain compliance, carbon data management and core competency stewardship, integrating sustainability considerations into business operations and value-chain management.

The 2025 ESG Report details Antaisolar’s performance across environmental, social and governance priorities. According to the report, green power accounted for 15.54% of Antaisolar’s energy consumption, while its self-built solar power plant generated 4,641,057 kWh of electricity annually. The report also highlights continued improvements in energy and emissions management, occupational health and safety, employee development, diversity and inclusion, community engagement, business ethics, risk management and information security, reflecting a more systematic approach to ESG management across the organization. It also links responsible product development and quality management with the company’s broader sustainability objectives, extending ESG considerations from internal operations to the wider industrial value chain. Key ESG data and practices disclosed in the report were independently assured by TÜV SÜD, enhancing the transparency, credibility and reliability of the disclosures.

Antaisolar also unveiled its 2026–2027 action plans for EcoRaise, its global ecological co-building initiative, covering four areas: environmental protection, biodiversity conservation, green energy development and sustainable lifestyles. In 2026, the company partnered with the Xiang’an Animal Protection Association to support the conservation of six national protected bird species through a dedicated donation, expanding its biodiversity efforts from plant conservation to wildlife protection.

Looking ahead, Antaisolar will continue to align its sustainability practices with the UNGC Ten Principles, advance the implementation of its RAISE strategy, and work with global partners to support the global transition toward green energy.

View original content:https://www.prnewswire.co.uk/news-releases/antaisolar-joins-united-nations-global-compact-and-releases-2025-esg-report-302859992.html